In vitro culture and drug sensitivity assay of Plasmodium falciparum with nonserum substitute and acute-phase sera

Journal of Clinical Microbiology

Volumn 37, Issue 3, 1999, Pages 700-705

  Ringwald, Pascal ^a,b   Meche, Fleurette Solange ^a   Bickii, Jean ^a   Basco, Leonardo K ^a  

^a Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

^b Institut de Recherche pour le Developpement Cameroon   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CYCLOGUANIL; DEETHYLAMODIAQUINE; DIHYDROARTEMISININ; HALOFANTRINE; PYRIMETHAMINE;

ACUTE PHASE RESPONSE; ADOLESCENT; ADULT; AGED; ARTICLE; CAMEROON; CHILD; CLINICAL ARTICLE; DRUG SCREENING; DRUG SENSITIVITY; HUMAN; NONHUMAN; PARASITE CULTIVATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

BOVINAE; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032996940     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.3.700-705.1999     Document Type: Article

References (40)

1. Asahi, H., and T. Kanazawa. 1994. Continuous cultivation of intraerythrocytic Plasmodium falciparum in a serum-free medium with the use of a growth-promoting factor. Parasitology 109:397-401.
2. Binh, V. Q., A. J. F. Luty, and P. G. Kremsner. 1997. Differential effects of human serum and cells on the growth of Plasmodium falciparum adapted to serum-free in vitro culture conditions. Am. J. Trop. Med. Hyg. 57:594-600.
3. 3H-hypoxanthine incorporation. Exp. Parasitol. 55:138-146.
4. Cranmer, S. L., C. Magowan, J. Liang, R. L. Coppel, and B. M. Cooke. 1997. An alternative to serum for cultivation of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 91:363-365.
5. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
6. Divo, A. A., and J. B. Jensen. 1982. Studies on serum requirements for the cultivation of Plasmodium falciparum. I. Animal sera. Bull. W. H. O. 60:565-569.
7. Flores, M. V. C., S. M. Berger-Eiszele, and T. S. Stewart. 1997. Long-term cultivation of Plasmodium falciparum in media with commercial non-serum supplements. Parasitol. Res. 83:734-736.
8. Gerold, P., L. Schofield, M. J. Blackman, A. A. Holder, and R. T. Schwarz. 1996. Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum. Mol. Biochem. Parasitol. 75:131-143.
9. Gillespie, S. H., C. Dow, J. G. Raynes, R. H. Behrens, P. L. Chiodini, and K. P. W. J. McAdam. 1991. Measurement of acute phase proteins for assessing severity of Plasmodium falciparum malaria. J. Clin. Pathol. 44:228-231.
10. Graninger, W., F. Thalhammer, U. Hollenstein, G. M. Zotter, and P. G. Kremsner. 1992. Serum protein concentrations in Plasmodium falciparum malaria. Acta Trop. 52:121-128.
11. Hawley, S. R., P. G. Bray, B. K. Park, and S. A. Ward. 1996. Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine. Mol. Biochem. Parasitol. 80:15-25.
12. 50 of halofantrine against Plasmodium falciparum. J. Pharm. Sci. 87:256-258.
13. Ifediba, T., and J. P. Vanderberg. 1980. Peptones and calf serum as a replacement for human serum in the cultivation of Plasmodium falciparum. J. Parasitol. 66:236-239.
14. Jensen, J. B. 1988. In vitro cultivation of malaria parasites: erythrocytic stages, p. 307-320. In W. H. Wernsdorfer and I. A. McGregor (ed.), Malaria. Principles and practice of malariology. Churchill Livingstone, Edinburgh, United Kingdom.
15. Lingnau, A., G. Margos, W. A. Maier, and H. M. Seitz. 1994. Serum-free cultivation of several Plasmodium falciparum strains. Parasitol. Res. 80:84-86.
16. Mansor, S. M., M. E. Molyneux, T. E. Taylor, S. A. Ward, J. J. Wirima, and G. Edwards. 1991. Effect of Plasmodium falciparum malaria infection on the plasma concentration of alpha 1-acid glycoprotein and the binding of quinine in Malawian children. Br. J. Clin. Pharmacol. 32:317-321.
17. Milhous, W. K., N. F. Weatherly, J. H. Bowdre, and R. E. Desjardins. 1985. In vitro activities of and mechanisms of resistance to antifol antimalarial drugs. Antimicrob. Agents Chemother. 27:525-530.
18. Mount, D. L., B. L. Nahlen, L. C. Patchen, and F. C. Churchill. 1989. Adaptations of the Saker-Solomons test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull. W. H. O. 67:295-300.
19. Oduola, A. M. J., B. M. Alexander, N. F. Weatherly, J. H. Bowdre, and R. E. Desjardins. 1985. Use of non-human plasma for in vitro cultivation and antimalarial drug susceptibility testing of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 34:209-215.
20. Oduola, A. M. J., O. A. T. Ogundahunsi, and L. A. Salako. 1992. Continuous cultivation and drug susceptibility testing of Plasmodium falciparum in a malaria endemic area. J. Protozool. 39:605-608.
21. Ofulla, A. V. O., V. C. N. Okoye, B. Khan, J. I. Githure, C. R. Roberts, A. J. Johnson, and S. K. Martin. 1993. Cultivation of Plasmodium falciparum parasites in a serum-free medium. Am. J. Trop. Med. Hyg. 49:335-340.
22. 50) of antimalarial drugs against Plasmodium falciparum parasites in a serum-free medium. Am. J. Trop. Med. Hyg. 51:214-218.
23. Ringwald, P., and L. K. Basco. Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaoundé, Cameroon. Bull. W. H. O., in press.
24. Ringwald, P., J. Bickii, and L. Basco. 1996. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347:24-28.
25. Ringwald, P., J. Bickii, and L. K. Basco. 1996. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. Am. J. Trop. Med. Hyg. 55:254-258.
26. Ringwald, P., J. Bickii, and L. K. Basco. 1998. Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children. Clin. Infect. Dis. 26:946-953.
27. Sax, L. J., and K. H. Rieckmann. 1980. Use of rabbit serum in the cultivation of Plasmodium falciparum. J. Parasitol. 66:621-624.
28. Siddiqui, W. A., and S. M. Richmond-Crum. 1977. Fatty acid-free bovine albumin as plasma replacement for in vitro cultivation of Plasmodium falciparum. J. Parasitol. 63:583-584.
29. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
30. Verdier, F., J. Le Bras, F. Clavier, I. Hatin, and M. C. Blayo. 1985. Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance. Antimicrob. Agents Chemother. 27:561-564.
31. Wang, P., M. Read, P. F. G. Sims, and J. E. Hyde. 1997. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol. Microbiol. 23:979-986.
32. Wanwimolruk, S., and J. R. Denton. 1992. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria. J. Pharm. Pharmacol. 44:806-811.
33. Warrell, D. A., M. E. Molyneux, and P. F. Beales. 1990. Severe and complicated malaria. Trans. R. Soc. Trop. Med. Hyg. 84(Suppl. 2):1-65.
34. Wernsdorfer, W. H. 1994. Epidemiology of drug resistance in malaria. Acta Trop. 56:143-156.
35. Wernsdorfer, W. H. 1997. Antimalarial drugs, p. 151-198. In G. Carosi and F. Castelli (ed.), Handbook of malaria infection in the tropics. Quaderni di cooperazione sanitaria, no. 15. Organizzazione per la Cooperazione Sanitaria Internazionale, Bologna, Italy.
36. Wernsdorfer, W. H., and D. Payne. 1988. Drug sensitivity tests in malaria parasites, p. 1765-1800. In W. H. Wernsdorfer and I. A. McGregor (ed.), Malaria. Principles and practice of malariology. Churchill Livingstone, Edinburgh, United Kingdom.
37. Willet, G. P., and C. J. Canfield. 1984. Plasmodium falciparum: continuous cultivation of erythrocyte stages in plasma-free culture medium. Exp. Parasitol. 57:76-80.
38. World Health Organization. 1997. In vitro micro-test (Mark III) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine/pyrimethamine and artemisinin: instructions for use of the in vitro micro-test kit (Mark III). Publication no. CTD/MAL/97.20. World Health Organization, Geneva, Switzerland.
39. Wright, J. D., F. D. Boudinot, and M. R. Ujhelyi. 1996. Measurement and analysis of unbound drug concentrations. Clin. Pharmacokinet. 30:445-462.
40. Yeo, A. E. T., K. K. Seymour, K. H. Rieckmann, and R. I. Christopherson. 1997. Effects of folic and folinic acids on the activities of cycloguanil and WR 99210 against Plasmodium falciparum in erythrocytic culture. Ann. Trop. Med. Parasitol. 91:17-23.